ArticleLung cancer (Amsterdam, Netherlands)2023

Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report.

Lauren Schmalz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.